PROMOTING ACCESS TO AFRICAN RESEARCH

Egyptian Journal of Medical Human Genetics

Log in or Register to get access to full text downloads.

Remember me or Register



Severe congenital neutropenia (Kostmann Syndrome)

SK Al-Jaouni

Abstract


Severe congenital neutropenia (SCN), Kostmann syndrome is a heterogenous disorder of myelopoiesis characterized by severe chronic neutropenia, absolute neutrophil count (ANC) persistently below 0.50 x 109/L, with maturation arrest of neutrophil precursors in the bone marrow; and associated with serious recurrent bacterial infections from early infancy. Sepsis mortality is reduced by an advent of granulocyte colony stimulating factor (G-CSF) therapy. More than 90% of patients respond to G-CSF therapy. However, hematopoietic stem cell transplantation has shown promise in the treatment of non-responders. About 60-80% of SCN cases are associated with constitutive mutations in one copy of the gene encoding neutrophil elastase ELA2. Myelodysplastic syndrome and acute myeloid leukemia (MDS/AML) have been reported. The hazard of MDS/AML increases significantly overtime. Approximately 10% of patients with severe congenital neutropenia develop AML. This is not thought to be the direct result of G-CSF therapy but related to the underlying disease itself.

Key Words: Myeloid leukemia, congenital neutropenia, kostmann’s syndrome, myelodysplastic syndrome.


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM




The Egyptian Journal Of Medical Human Genetics.   ISSN: 1110-8630
AJOL African Journals Online